Test code: 4369
Effective update from 21/02/2020
PREVIOUS |
NEW
|
These results should be interpreted cautiously taking into account the clinical picture; medical history and complementary tests, such as digital-rectal examination (DRE) tests. PHI (Prostate Health Index) is a predictor of risk of developing prostate cancer which is calculated by integrating the total value of PSA, free PSA value and Pro PSA. This calculation is favorable for total PSA values between 2 and 10 ng / mL. Index PHI Chance of developing prostate cancer (95% specificity) 0 - 20.9 1.9 - 16.1% 21- 40 17.3 - 24.6% >40 36.0 - 52.9% Prostate biopsy continues to be the gold standard for prostate cancer detection. | These results should be interpreted cautiously taking into account the clinical picture; medical history and complementary tests, such as digital-rectal examination (DRE) tests. PHI (Prostate Health Index) is a predictor of risk of developing prostate cancer which is calculated by integrating the total value of PSA, free PSA value and Pro PSA. This calculation is favorable for total PSA values between 2 and 10 ng / mL. Index PHI Chance of developing prostate cancer (95% specificity) 0 - 20.9 Lower risk 21- 40 Moderated risk >40 High Risk Prostate biopsy continues to be the gold standard for prostate cancer detection. |
Find the record of the test by clicking here
No comments:
Post a Comment